Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells
Author:
Affiliation:
1. Department of Clinical Pharmacology, College of Pharmacy; Dalian Medical University; China
2. Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning; Dalian Medical University; China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference29 articles.
1. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies;Aggarwal;Anticancer Res,2004
2. An intracellular signal pathway that regulates cancer cell adhesion in response to extracellular forces;Basson;Cancer Res,2008
3. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation;Brognard;Cancer Res,2001
4. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway;Chen;Cancer Biol Ther,2015
5. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism;Chiarini;Leukemia,2008
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases;Frontiers in Immunology;2024-06-19
2. Deciphering the Role of Exosomal Non-Coding RNA (ncRNA) in Drug Resistance of Gastrointestinal Tumors; an Updated Review;Cell Biochemistry and Biophysics;2024-06
3. Bestatin attenuates breast cancer stemness by targeting puromycin-sensitive aminopeptidase;Discover Oncology;2024-05-30
4. Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders;Brain Research;2024-05
5. Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer;Nutrients;2024-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3